Neogen Corporation shareholders approved the Amended and Restated Omnibus Incentive Plan at their annual meeting on October 1, 2026. The new plan replaces the existing 2023 Omnibus Incentive Plan. It authorizes up to 31,350,000 shares for equity-based awards.
The company disclosed this vote in an amended Form 8-K filed with the Securities and Exchange Commission on October 26, 2026. Chief Financial Officer R. Bryan Riggsbee signed the amendment. It adds Item 5.02 disclosure regarding the shareholder vote. The original Form 8-K, filed on October 7, 2026, did not detail this compensatory arrangement.
Neogen may grant various equity-based awards under the new plan. Recipients include non-employee directors and all employees of the company or its subsidiaries. Named executive officers are also eligible. Awards can take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance stock units, and other stock-based awards. The maximum share count of 31,350,000 is subject to certain adjustments.
The plan was previously detailed in Neogen's proxy statement filed with the SEC on August 21, 2026. A copy of the Amended and Restated Omnibus Incentive Plan is attached as Exhibit 10.1 to the amended filing. Neogen is incorporated in Michigan and maintains its principal executive offices at 620 Lesher Place in Lansing. Its common stock, with a par value of $0.16 per share, trades on the Nasdaq Global Select Market under the ticker symbol NEOG.